DDU384: A new preclinical candidate for the treatment of Tuberculosis
Simon R. Green, Kirsteen I. Buchanan, Helena I. Boshoff, Paul J. Koovits, Dinakaran Murugesan, Cristina De Cozar-Gallardo, Ana Yepes, Eik Hoffmann, Lisa M. Massoudi, Paul J. Converse, Oliver D. Komm, Laura Guijarro-López, Patricia Casado, Paul Scullion, Adolfo García-Pérez, , Laura A. T. Cleghorn
This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.
bioRxiv · Oct 27, 2026 · PreprintMicrobiology